Through this study, we found that YXF can increase miR133a and inhibit the expression of the TGF‐β/Smads pathway, thereby inhibiting myocardial fibrosis and exerting a protective effect on DCM. The gene discussed is TGFB1; the disease is Myocardial fibrosis.